WELLS FARGO & COMPANY/MN - GALMED PHARMACEUTICALS LTD ownership

GALMED PHARMACEUTICALS LTD's ticker is GLMD and the CUSIP is M47238106. A total of 9 filers reported holding GALMED PHARMACEUTICALS LTD in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
WELLS FARGO & COMPANY/MN ownership history of GALMED PHARMACEUTICALS LTD
ValueSharesWeighting
Q1 2023$1,301
-14.7%
3,0500.0%0.00%
Q4 2022$1,525
+52.5%
3,050
-24.7%
0.00%
Q3 2022$1,000
-75.0%
4,050
-36.0%
0.00%
Q2 2022$4,000
-60.0%
6,3300.0%0.00%
Q1 2022$10,000
-16.7%
6,3300.0%0.00%
Q4 2021$12,000
-33.3%
6,3300.0%0.00%
Q3 2021$18,000
-5.3%
6,3300.0%0.00%
Q2 2021$19,000
-9.5%
6,3300.0%0.00%
Q1 2021$21,000
+5.0%
6,3300.0%0.00%
Q4 2020$20,000
-13.0%
6,3300.0%0.00%
Q3 2020$23,000
-23.3%
6,3300.0%0.00%
Q2 2020$30,000
+42.9%
6,3300.0%0.00%
Q1 2020$21,000
-43.2%
6,3300.0%0.00%
Q4 2019$37,000
+640.0%
6,330
+533.0%
0.00%
Q3 2019$5,000
-37.5%
1,000
-13.0%
0.00%
Q2 2019$8,000
-68.0%
1,150
-62.5%
0.00%
Q1 2019$25,000
+78.6%
3,070
+48.3%
0.00%
Q4 2018$14,000
-95.3%
2,070
-90.5%
0.00%
Q3 2018$297,000
+1137.5%
21,900
+338.0%
0.00%
Q1 2017$24,000
+33.3%
5,0000.0%0.00%
Q4 2016$18,000
-45.5%
5,000
-33.3%
0.00%
Q3 2016$33,000
+65.0%
7,500
+274.4%
0.00%
Q2 2015$20,000
-47.4%
2,003
-50.0%
0.00%
Q1 2015$38,000
+171.4%
4,006
+65.9%
0.00%
Q4 2014$14,000
-98.6%
2,414
-98.0%
0.00%
Q3 2014$1,022,000118,7810.00%
Other shareholders
GALMED PHARMACEUTICALS LTD shareholders Q1 2017
NameSharesValueWeighting ↓
BVF INC/IL 1,347,755$574,8180.02%
Virtu Financial LLC 31,633$130.00%
Western Wealth Management, LLC 29,537$12,5970.00%
Belpointe Asset Management LLC 14,050$5,9920.00%
TSFG, LLC 3,000$10.00%
ZRC WEALTH MANAGEMENT, LLC 100$430.00%
Allworth Financial LP 250$1070.00%
JANE STREET GROUP, LLC 13,189$5,6250.00%
RAYMOND JAMES & ASSOCIATES 138,040$58,8740.00%
BOURGEON CAPITAL MANAGEMENT LLC 500$2140.00%
View complete list of GALMED PHARMACEUTICALS LTD shareholders